Advanced search
Publication Cover
Acta Oncologica Volume 41, 2002 - Issue 7-8
Journal homepage
313
Views
3
CrossRef citations to date
0
Altmetric
Research Article

Patient Preference for Dissection of Sentinel Nodes Outside Level I-II of the Axilla

Marjut H. Leidenius From the Breast Surgery Unit, Maria Hospital (M.H. Leidenius, K.A. von Smitten) and the Department of Oncology (P.S. Hietanen), Helsinki University Hospital, Helsinki, Finland
,
Karl A. Von Smitten From the Breast Surgery Unit, Maria Hospital (M.H. Leidenius, K.A. von Smitten) and the Department of Oncology (P.S. Hietanen), Helsinki University Hospital, Helsinki, Finland
&
Päivi S. Hietanen From the Breast Surgery Unit, Maria Hospital (M.H. Leidenius, K.A. von Smitten) and the Department of Oncology (P.S. Hietanen), Helsinki University Hospital, Helsinki, Finland
Pages 652-658 | Published online: 08 Jul 2009

  • Morrow M, Foster RS. Staging of breast cancer. A new rationale for internal mammary node biopsy. Arch Surg 1981; 166: 748-51.
  • Veronesi U, Cascinelli N, Greco M, et al. Prognosis of breast cancer patients after mastectomy and dissection of internal mammary nodes. Ann Surg 1985; 202: 702-7.
  • Noguchi M, Ohta N, Kioyasaki N, Taniya T, Miyazaki I, Mizukami Y. Reappraisal of internal mammary node métastases as a prognostic factor in patients with breast cancer. Cancer 1991; 68: 1918-25.
  • Arriagada R, Guinebretiere J-M, Le ME. Do internal mammary chain nodes matter in the prognosis of axillary nodenegative breast cancer? Acta Oncol 2000; 39: 307-8.
  • Arriagada R, Le ME. Adjuvant radiotherapy in breast cancer. The treatment of lymph node areas. Acta Oncol 2000; 39: 295-305.
  • Freedman GM, Fowble BL, Nicolau N, et al. Should internal mammary lymph nodes in breast cancer be a target for the radiation oncologist? Int J Radiat Oncol Biol Phys 2000; 46: 805-14.
  • O'Hea BJ, Hill ADK, El-Shirbiny AM, et al. Sentinel lymph node biopsy in breast cancer: initial experience at Memorial Sloan-Kettering Cancer Center. J Am Coll Surg 1998; 186: 423-7.
  • Krag D, Weaver D, Ashikaga T, et al. The sentinel node in breast cancer. A multicenter validation study. N Engl J Med 1998; 339: 941-6.
  • Borgstein PJ, Pijpers R, Comans EF, van Diest PJ, Boom RP, Meijer S. Sentinel lymph node biopsy in breast cancer: guidelines and pitfalls of lymphoscintigraphy and gamma probe detection. J Am Coll Surg 1998; 186: 275-83.
  • Haigh PI, Hansen NM, Giuliano AE, Edwards K, Ye W, Glass EC. Factors affecting sentinel node localization during preoperative breast lymphoscintigraphy. J Nucl Med 2000; 41: 1682-8.
  • Jansen L, Doting MHE, Rutgers EJTh, de Vries J, Valdés Olmos RA, Nieweg OE. Clinical relevance of sentinel lymph nodes outside the axilla in patients with breast cancer. Br J Surg 2000; 87: 920-5.
  • Uren RF, Howman-Giles R, Renwick SB, Gillet D. Lymphatic mapping of the breast cancer locating the sentinel lymph nodes. World J Surg 2001; 25: 789-93.
  • van der Ent FWC, Kengen RAM, van der Pol HAG, Povel JACM, Stroeken HJG, Hoofwijk AGM. Halstedt revisited: internal mammary sentinel lymph node biopsy in breast cancer. Ann Surg 2001; 234: 79-84.
  • Valdés Olmos RA, Tanis PJ, Hoefnagel CA, et al. Improved sentinel node visualization in breast cancer by optimizing the colloid particle concentration and tracer dosage. Nucl Med Commun 2001; 22: 579-86.
  • Galper SR, Lee SJ, Tao ML, et al. Patient preference for axillary dissection in the management of early-stage breast cancer. J Natl Cancer Inst 2000; 92: 1681-7.
  • Fleissig A, Jenkins V, Fallowfield L. Results of an intervention study to improve communication about randomised clinical trials of cancer therapy. Eur J Cancer 2001; 37: 322-31.
  • Hietanen P, Aro AR, Holli K, Absetz P. Information and communication in the context of a clinical trial. Eur J Cancer 2000; 36: 2096-104.
  • Daugherty CK. Impact of therapeutic research on informed consent and the ethics of clinical trials: a medical oncology perspective. J Clin Oncol 1999; 17: 1601-17.
  • Hayman JA, Fairclough DL, Harris JR, Weeks JC. Patient preferences concerning the trade-off between the risks and benefits of routine radiation therapy after conservative surgery for early-stage breast cancer. J Clin Oncol 1997; IS: 1252-60.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.